Phosphocitrate Is Potentially a Disease-Modifying Drug for Noncrystal-Associated Osteoarthritis
Figure 1
PC inhibits the proliferation of OA FLSs. (a)There were about 65% fewer hTERT-OA 13A FLSs in the PC-treated wells after nine days of culture compared to those in the untreated wells (). (b) PC and EHDP inhibited the proliferation of primary OA FLSs in a dose-dependent manner.
